BioLineRx Ltd (BLRX) — Tangible Net Worth Ratio
BioLineRx Ltd (BLRX) has a Tangible Net Worth Ratio of 29.9% as of December 2025. This metric is calculated by deducting intangible assets ($16.37 Million) from net assets ($23.34 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See BioLineRx Ltd book value and equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
BioLineRx Ltd Tangible Net Worth Ratio (2008–2025)
This chart shows how BioLineRx Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 29.9%, reflecting net assets of $23.34 Million with intangible assets of $16.37 Million USD. Also explore BioLineRx Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for BioLineRx Ltd (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see BioLineRx Ltd (BLRX) total market value.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.9% | $23.34 Million | $16.37 Million | $40.90 Million | ▲ +7.5 pp |
| 2024 | 22.4% | $13.46 Million | $10.45 Million | $38.91 Million | ▲ +34.7 pp |
| 2023 | -12.3% | $13.22 Million | $14.85 Million | $63.92 Million | ▼ -69.3 pp |
| 2022 | 57.0% | $50.84 Million | $21.89 Million | $76.38 Million | ▼ -11.2 pp |
| 2021 | 68.1% | $68.09 Million | $21.70 Million | $81.39 Million | ▲ +66.7 pp |
| 2020 | 1.4% | $22.03 Million | $21.71 Million | $47.29 Million | ▼ -33.0 pp |
| 2019 | 34.4% | $33.38 Million | $21.89 Million | $53.57 Million | ▼ -12.4 pp |
| 2018 | 46.8% | $41.32 Million | $21.97 Million | $56.23 Million | ▼ -39.9 pp |
| 2017 | 86.7% | $52.88 Million | $7.02 Million | $60.97 Million | ▼ -12.8 pp |
| 2016 | 99.5% | $35.03 Million | $181.00K | $38.94 Million | ▼ -0.2 pp |
| 2015 | 99.7% | $47.61 Million | $152.00K | $51.30 Million | ▲ +0.1 pp |
| 2014 | 99.6% | $31.77 Million | $117.36K | $36.17 Million | ▲ +1.8 pp |
| 2013 | 97.8% | $11.68 Million | $252.12K | $19.95 Million | ▼ -0.3 pp |
| 2012 | 98.1% | $14.97 Million | $284.53K | $24.31 Million | ▼ -0.6 pp |
| 2011 | 98.7% | $22.53 Million | $300.58K | $29.34 Million | ▼ -0.3 pp |
| 2010 | 99.0% | $37.26 Million | $381.76K | $43.66 Million | ▲ +1.6 pp |
| 2009 | 97.4% | $31.13 Million | $803.06K | $42.02 Million | ▲ +1.5 pp |
| 2008 | 95.9% | $20.75 Million | $848.56K | $30.64 Million | — |